The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival following enzalutamide resistance in metastatic castration-sensitive versus metastatic castration-resistant prostate cancer.
 
Taro Iguchi
Consulting or Advisory Role - Astellas Pharma; Bayer Yakuhin
Speakers' Bureau - Astellas Pharma; AstraZeneca Japan; Bayer Yakuhin; Daiichi Sankyo; Eisai; Janssen; Kissei Pharmaceutical; MSD; Nippon Shinyaku; Sanofi; Takeda; Teleflex Medical
Research Funding - Astellas Pharma; Bayer
 
Taisuke Matsue
No Relationships to Disclose
 
Minoru Kato
Consulting or Advisory Role - Astellas Amgen BioPharama; Bristol-Myers Squibb Japan; MSD; Ono Yakuhin; Pfizer
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb Japan; MC Medical; Merck; MSD; Nippon Kayaku; Ono Yakuhin; Pfizer
 
Nobuyo Morita
No Relationships to Disclose
 
Kenshiro Kunii
No Relationships to Disclose
 
Ippei Chikazawa
No Relationships to Disclose
 
Tatsuro Tanaka
No Relationships to Disclose
 
Katsuhito Miyazawa
No Relationships to Disclose